GutBetter will provide an innovative, disruptive solution which will answer the unmet needs of 20-40% of the population who suffer from DGBI (Disorders of Gut-Brain Interaction). Currently, patients with such conditions suffer for years (with IBS, pain, diarrhoea, constipation, etc.), and GPs and gastroenterologists cannot find the cause of their symptoms (because there are no physical indicators such as ulcers or viruses). After proving its effectiveness and cost-effectiveness in this project’s clinical trial, they’ll be massive demand for GutBetter in the UK, USA and globally.
We’ll provide TeleHealth solutions enabling GPs to prescribe GutBetter to their patients, saving time and cost and reducing patients’ symptoms better than existing interventions. It’ll include options for nurses/therapists to remotely provide blended therapy to their patients and track/monitor their progress.
GutBetter will help and empower millions who’ve suffered for years from IBS, pain, diarrhoea, and constipation (for whom medication and the medical profession haven’t been able to help) to improve their quality of life.